Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

SIRS-Lab Appoints Executive Vice-President, Corporate Development

SIRS-Lab Gmbh (SIRS-Lab) has appointed Edward Currie as executive vice-president, corporate development of the company. In this newly created role, Edward will drive partnering, licensing, companion diagnostics, and corporate business development activities at SIRS-Lab. Edward, a physician specialized in clinical microbiology and infectious disease, brings 20 years of diagnostic and pharmaceutical industry experience at Eli Lilly, F. Hoffmann-La Roche, IBM.

Most recently, Edward served as chief operating officer of Kuros BioSurgery. At Roche, as global head of disease management, Edward created the company’s first integrated Pharma-Diagnostic approach for targeted treatment and personalized medicine.

On his decision to join SIRS-Lab, Edward commented “I am very excited to be joining SIRS-Lab, a highly innovative company that I believe can make a real difference to the outcomes of patients with sepsis and life-threatening infections.”

Stefan Russwurm, chief executive officer of SIRS-Lab, stated: “We are delighted to welcome Dr. Currie here at SIRS-Lab. His highly regarded wealth of experience and an impressive track-record in the medical and diagnostic area, especially in the field of personalized medicine, will benefit us greatly in expanding our strategic partnerships.”